Gene Therapy
Cambria Biosciences Unveils Novel Epilepsy Drug Discovery Program at the Neurotechnology Industry Organization Conference
Published in Drug Law Weekly, June 5th, 2007
Cambria Biosciences today unveiled a novel approach to discovering epilepsy drugs by utilizing an intact animal nervous system engineered for high-throughput screening. The process was described in a presentation made by Dr. Leo Liu, President and Chief Executive Officer at Cambria, at the 2nd Annual Neurotechnology Industry Organization Conference. The Company is currently using this discovery platform to build a pipeline of new epilepsy drug leads.
Dr. Liu explained, "Genetic studies have shown that epilepsy genes and proteins are highly conserved between fruit flies and humans. Cambria has engineered a high-throughput in vivo disease model that utilizes the whole...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2007-06-05)
More Articles from Drug Law Weekly
- Drug Development
Hispanics and African Americans Among Those at Risk Due to High Cost of Prescription Drugs Says AARP National Study - Drug Development
Teva Provides Update on Generic Celebrex Litigation - Financing
Vasogen Closes Previously Announced Financing - Medicare and Medicaid
National Community Pharmacists Association's Legislative Conference Receives Congressional Pledges to Take Action on Issues That Affect Patients - Patents
Novartis defends its intellectual property rights as US court issues order prohibiting Teva from selling a generic version of Lotrel - Patents
Novartis pursues legal actions to defend intellectual property rights for high blood pressure medicine Lotrel following US court ruling - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
